Prim S.A.
Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic pr… Read more
Prim S.A. (PRM) - Total Liabilities
Latest total liabilities as of June 2025: €75.24 Million EUR
Based on the latest financial reports, Prim S.A. (PRM) has total liabilities worth €75.24 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Prim S.A. - Total Liabilities Trend (2004–2024)
This chart illustrates how Prim S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Prim S.A. Competitors by Total Liabilities
The table below lists competitors of Prim S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Daiken Biomedical Co., Ltd.
TW:7780
|
Taiwan | NT$304.81 Million |
|
CARGO Therapeutics, Inc. Common Stock
NASDAQ:CRGX
|
USA | $20.91 Million |
|
Hangzhou Flariant Co Ltd
SHG:605566
|
China | CN¥555.35 Million |
|
Bintulu Port Holdings Bhd
KLSE:5032
|
Malaysia | RM1.36 Billion |
|
Gansu Mogao Industrial Development Co Ltd
SHG:600543
|
China | CN¥222.86 Million |
|
Capital Limited
PINK:CAPFF
|
USA | $250.37 Million |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$6.86 Billion |
|
Saha Pathanapibul Public Company Limited
BK:SPC
|
Thailand | ฿9.88 Billion |
Liability Composition Analysis (2004–2024)
This chart breaks down Prim S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Prim S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Prim S.A. (2004–2024)
The table below shows the annual total liabilities of Prim S.A. from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €61.34 Million | -17.41% |
| 2023-12-31 | €74.28 Million | +13.78% |
| 2022-12-31 | €65.28 Million | +11.83% |
| 2021-12-31 | €58.38 Million | +12.47% |
| 2020-12-31 | €51.90 Million | +34.44% |
| 2019-12-31 | €38.61 Million | +31.01% |
| 2018-12-31 | €29.47 Million | -7.03% |
| 2017-12-31 | €31.70 Million | +15.49% |
| 2016-12-31 | €27.45 Million | +14.52% |
| 2015-12-31 | €23.97 Million | +0.37% |
| 2014-12-31 | €23.88 Million | +0.36% |
| 2013-12-31 | €23.79 Million | -10.87% |
| 2012-12-31 | €26.69 Million | -41.59% |
| 2011-12-31 | €45.70 Million | +5.61% |
| 2010-12-31 | €43.27 Million | +14.61% |
| 2009-12-31 | €37.76 Million | -4.77% |
| 2008-12-31 | €39.65 Million | +7.57% |
| 2007-12-31 | €36.86 Million | -8.12% |
| 2006-12-31 | €40.12 Million | -5.65% |
| 2005-12-31 | €42.52 Million | +28.20% |
| 2004-12-31 | €33.17 Million | -- |